Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis

References

• Abe Y, Hashimoto S, Horie T. (1999). Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39:41–7.
   PubMed Web of Science ®Google Scholar
• Ackermann RT, Mulrow CD, Ramirez G, et al. (2001). Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 161:813.
   PubMed Web of Science ®Google Scholar
• Adamo RF, Fishbein I, Zhang K, et al. (2016). Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries. J Control Release 222:169–75.
   PubMed Web of Science ®Google Scholar
• Aguilar EC, Leonel AJ, Teixeira LG, et al. (2014). Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation. Nutr Metab Cardiovasc Dis 24:606–13.
   PubMed Web of Science ®Google Scholar
• Akazawa N, Choi Y, Miyaki A, et al. (2012). Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr Res 32:795–9.
   PubMed Web of Science ®Google Scholar
• Allijn IE, Czarny BMS, Wang X, et al. (2017). Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. J Control Release 247:127–33.
   PubMed Web of Science ®Google Scholar
• Ambrosioni E, Bacchelli S, Degli Esposti D, Borghi C. (1992). ACE-inhibitors and atherosclerosis. Eur J Epidemiol 8:129–33.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Modery-Pawlowski CL, Menegatti S, et al. (2014). Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano 8:11243–53.
   PubMed Web of Science ®Google Scholar
• Arab L, Steck S. (2000). Lycopene and cardiovascular disease. Am J Clin Nutr 71:1691S–5S.
   PubMed Web of Science ®Google Scholar
• Ashor AW, Lara J, Mathers JC, Siervo M. (2014). Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials. Atherosclerosis 235:9–20.
   PubMed Web of Science ®Google Scholar
• Bartneck M, Peters FM, Warzecha KT, et al. (2014). Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages. Nanomed Nanotechnol Biol Med 10:1209–20.
   PubMed Web of Science ®Google Scholar
• Bejarano J, Navarro-Marquez M, Morales-Zavala F, et al. (2018). Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches. Theranostics 8:4710–32.
   PubMed Web of Science ®Google Scholar
• Beldman TJ, Malinova TS, Desclos E, et al. (2019). Nanoparticle-aided characterization of arterial endothelial architecture during atherosclerosis progression and metabolic therapy. ACS Nano 13:13759–74.
   PubMed Web of Science ®Google Scholar
• Berbée JFP, Wong MC, Wang Y, et al. (2013). Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE * 3-Leiden.CETP mice. J. Nutr. Biochem 24:1423–30.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, et al. (2014). Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25.
   PubMed Web of Science ®Google Scholar
• Biesalski HK. (2002). Nutraceuticals: the link between nutrition and medicine. J Toxicol - Cutan Ocul Toxicol 21:9–30.
   Web of Science ®Google Scholar
• Bitzur R, Cohen H, Kamari Y, Harats D. (2013). Intolerance to statins: mechanisms and management. Diabetes Care 36:S325–S30.
   PubMed Web of Science ®Google Scholar
• Borriello A, Cucciolla V, Della Ragione F, Galletti P. (2010). Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis 20:618–25.
   PubMed Web of Science ®Google Scholar
• Bronte-Stewart B, Heptinstall RH. (1954). The relationship between experimental hypertension and cholesterol-induced atheroma in rabbits. J Pathol Bacteriol 68:407–17.
   PubMedGoogle Scholar
• Brown BE, Kim CHJ, Torpy FR, et al. (2014). Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice. Atherosclerosis 232:403–9.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Takasu J, Flores FR, et al. (2004). Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: a preliminary study. Prev Med 39:985–91.
   PubMed Web of Science ®Google Scholar
• Bühler FR, Laragh JH, Baer L, et al. (1972). Propranolol inhibition of renin secretion: a specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 287:1209–14.
   PubMed Web of Science ®Google Scholar
• Bulgarelli A, Leite ACA, Dias AAM, Maranhão RC. (2013). Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to ldl receptors in cholesterol-fed rabbits. Cardiovasc Drugs Ther 27:531–9.
   PubMed Web of Science ®Google Scholar
• Burnouf T, Goubran HA, Chen TM, et al. (2013). Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev 27:77–89.
   PubMed Web of Science ®Google Scholar
• Carluccio MA, Sicullela L, Ancora MA, et al. (2003). Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23:622–9.
   PubMed Web of Science ®Google Scholar
• Cavalcanti Neto MP, Aquino JdS, Romão da Silva LdF, et al. (2018). Gut microbiota and probiotics intervention: a potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?. Pharmacol Res 130:152–63.
   PubMed Web of Science ®Google Scholar
• Cheng WE, Chang MY, Wei JY, et al. (2015). Berberine reduces Toll-like receptor-mediated macrophage migration by suppression of Src enhancement. Eur J Pharmacol 757:1–10.
   PubMed Web of Science ®Google Scholar
• Chmielowski RA, Abdelhamid DS, Faig JF, et al. (2017). Athero-inflammatory nanotherapeutics: ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation. Acta Biomater 57:85–94.
   PubMed Web of Science ®Google Scholar
• Chuengsamarn S, Rattanamongkolgul S, Phonrat B, et al. (2014). Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem 25:144–150.
   PubMed Web of Science ®Google Scholar
• Cicero AFG, Colletti A, Bajraktari G, et al. (2017). Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 75:731–67.
   PubMed Web of Science ®Google Scholar
• Cormode DP, Roessl E, Thran A, et al. (2010). Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 256:774–82.
   PubMed Web of Science ®Google Scholar
• Damiano MG, Mutharasan RK, Tripathy S, et al. (2013). Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery. Adv Drug Deliv Rev 65:649–62.
   PubMed Web of Science ®Google Scholar
• de Courten B, Jakubova M, de Courten MP, et al. (2016). Effects of carnosine supplementation on glucose metabolism: pilot clinical trial. Obesity 24:1027–34.
   PubMed Web of Science ®Google Scholar
• Dell’Agli M, Fagnani R, Mitro N, et al. (2006). Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation. J Agric Food Chem 54:3259–64.
   PubMed Web of Science ®Google Scholar
• Deshun L, Kassab GS. (2011). Role of shear stress and stretch in vascular mechanobiology. J R Soc Interfaceface 8:137.
   Web of Science ®Google Scholar
• Dong H, Zhao Y, Zhao L, Lu F. (2013). The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med 79:437–46.
   PubMed Web of Science ®Google Scholar
• Duivenvoorden R, Tang J, Cormode DP, et al. (2014). A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat Commun 5:3065.
   PubMed Web of Science ®Google Scholar
• Egawa G, Nakamizo S, Natsuaki Y, et al. (2013). Intravital analysis of vascular permeability in mice using two-photon microscopy. Sci Rep 3:1932.
   PubMed Web of Science ®Google Scholar
• Ehrenstein MR, Jury EC, Mauri C. (2005). Statins for atherosclerosis-as good as it gets?. N Engl J Med 352:73–5.
   PubMed Web of Science ®Google Scholar
• Estruch R, Ros E, Salas-Salvadó J, et al. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 378:e34.
   Web of Science ®Google Scholar
• Evans RJ, Lavin B, Phinikaridou A, et al. (2020). Targeted molecular iron oxide contrast agents for imaging atherosclerotic plaque. Nanotheranostics 4:184–94.
   PubMedGoogle Scholar
• Falk E. (2006). Pathogenesis of atherosclerosis. J Am Coll Cardiol 47:C7–12.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu C-MJ, Luk BT, et al. (2014). Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14:2181–8.
   PubMed Web of Science ®Google Scholar
• Ferrières J. (2004). The French paradox: lessons for other countries. Heart 90:107–11.
   PubMed Web of Science ®Google Scholar
• Fitó M, Cladellas M, de la Torre R, et al. (2008). Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. Eur J Clin Nutr 62:570–4.
   PubMed Web of Science ®Google Scholar
• Flores AM, Hosseini-Nassab N, Jarr K-U, et al. (2020). Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat Nanotechnol 15:154–61.
   PubMed Web of Science ®Google Scholar
• Flores AM, Ye J, Jarr KU, et al. (2019). Nanoparticle therapy for vascular diseases. ATVB 39:635–46.
   Google Scholar
• Fogacci F, Banach M, Mikhailidis DP, et al. (2019). Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 143:1–16.
   PubMed Web of Science ®Google Scholar
• Frank-Kamenetsky M, Grefhorst A, Anderson AA, et al. (2008). Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci USA 105:11915–20.
   PubMed Web of Science ®Google Scholar
• Franzese CJ, Bliden KP, Gesheff MG, et al. (2015). Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy. Am J Cardiol 115:1204–11.
   PubMed Web of Science ®Google Scholar
• Gao C, Huang Q, Liu C, et al. (2020). Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat Commun 11:2622.
   PubMed Web of Science ®Google Scholar
• Gao L, Mao Q, Cao J, et al. (2012). Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 221:311–16.
   PubMed Web of Science ®Google Scholar
• Gao S, Zhou J, Liu N, et al. (2015). Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. J Mol Cell Cardiol 85:131–9.
   PubMed Web of Science ®Google Scholar
• García-Villalba R, Carrasco-Pancorbo A, Nevedomskaya E, et al. (2010). Exploratory analysis of human urine by LC-ESI-TOF MS after high intake of olive oil: understanding the metabolism of polyphenols. Anal Bioanal Chem 398:463–75.
   PubMed Web of Science ®Google Scholar
• Gavrila D, Li WG, McCormick ML, et al. (2005). Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25:1671–7.
   PubMed Web of Science ®Google Scholar
• Getts DR, Terry RL, Getts MT, et al. (2014). Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med 6:219ra7.
   PubMed Web of Science ®Google Scholar
• Giannini F, Candilio L, Mitomo S, et al. (2018). A practical approach to the management of complications during percutaneous coronary intervention. JACC: Cardiovasc Interven 11:1797–810.
   PubMed Web of Science ®Google Scholar
• Glass CK, Witztum JL. (2001). Atherosclerosis. the road ahead. Cell 104:503–16.
   PubMed Web of Science ®Google Scholar
• González-Santiago M, Martín-Bautista E, Carrero JJ, et al. (2006). One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis 188:35–42.
   PubMed Web of Science ®Google Scholar
• Gorinstein S, Leontowicz H, Lojek A, et al. (2002). Olive oils improve lipid metabolism and increase antioxidant potential in rats fed diets containing cholesterol. J Agric Food Chem 50:6102–8.
   PubMed Web of Science ®Google Scholar
• Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, et al. (2010). Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev 68:191–206.
   PubMed Web of Science ®Google Scholar
• Guivernau M, Meza N, Barja P, Roman O. (1994). Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins, Leukot Essent Fat Acids 51:311–6.
   PubMed Web of Science ®Google Scholar
• Guo X, Li Z, Vittinghoff E, et al. (2018). Trends in rate of acute myocardial infarction among patients aged <30 years. Nat Rev Cardiol 15:119.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhao R, Xu F. (2018). Neutrophil-based delivery systems for nanotherapeutics. Small 14:1801674.
   PubMed Web of Science ®Google Scholar
• Hansson GK. (2005). Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–95.
   PubMed Web of Science ®Google Scholar
• Harel-Adar T, Ben Mordechai T, Amsalem Y, et al. (2011). Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci USA 108:1827–32.
   PubMed Web of Science ®Google Scholar
• Heiss C, Sansone R, Karimi H, et al. (2015). Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial. Age 37:9794.
   PubMedGoogle Scholar
• Herman LL, Padala PA, Bashir K. (2019). Angiotensin converting enzyme inhibitors (ACEI). Treasure Island (FL): StatPearls Publishing.
   Google Scholar
• Higgins JP. (2003). Can angiotensin-converting enzyme inhibitors reverse atherosclerosis? South Med J 96:569–79.
   PubMed Web of Science ®Google Scholar
• Hsu SP, Wu M-S, Yang C-C, et al. (2007). Chronic green tea extract supplementation reduces hemodialysisenhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am J Clin Nutr 86:1539–47.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 108:10980–5.
   PubMed Web of Science ®Google Scholar
• Hughes DA, Southon S, Pinder AC. (1996). (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 126:603–10.
   PubMed Web of Science ®Google Scholar
• Hyafil F, Cornily J-C, Feig JE, et al. (2007). Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 13:636–41.
   PubMed Web of Science ®Google Scholar
• Insull W. (2006). Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review. South Med J 99:257–73.
   PubMed Web of Science ®Google Scholar
• Ito MK. (2015). Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature. Atherosclerosis 242:647–656.
   PubMed Web of Science ®Google Scholar
• Iverson NM, Plourde NM, Sparks SM, et al. (2011). Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation. Biomaterials 32:8319–27.
   PubMed Web of Science ®Google Scholar
• Jayagopal A, Linton MF, Fazio S, Haselton FR. (2010). Insights into atherosclerosis using nanotechnology. Curr Atheroscler Rep 12:209–15.
   PubMed Web of Science ®Google Scholar
• Jeong HW, Hsu KC, Lee J-W, et al. (2009). Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol - Endocrinol Metab 296:E955–64.
   PubMed Web of Science ®Google Scholar
• Jin K, Luo Z, Zhang B, Pang Z. (2018). Biomimetic nanoparticles for inflammation targeting. Acta Pharm Sin B 8:23–33.
   PubMed Web of Science ®Google Scholar
• Johnston TP, Korolenko TA, Pirro M, Sahebkar A. (2017). Preventing cardiovascular heart disease: promising nutraceutical and non-nutraceutical treatments for cholesterol management. Pharmacol Res 120:219–25.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Fredman G, Subramanian M, et al. (2013). Development and in vivo efficacy of targeted polymeric inflammation- resolving nanoparticles. Proc Natl Acad Sci USA 110:6506–11.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Fredman G, Fojas JJR, et al. (2016). Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis. ACS Nano 10:5280–92.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Yameen B, Wu J, Farokhzad OC. (2016). Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev 116:2602–63.
   PubMed Web of Science ®Google Scholar
• Katan MB, Grundy SM, Jones P, et al. (2003). Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78:965–78.
   PubMed Web of Science ®Google Scholar
• Katsuki S, Matoba T, Nakashiro S, et al. (2014). Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes. Circulation 129:896–906.
   PubMed Web of Science ®Google Scholar
• Keys A. (1997). Coronary heart disease in seven countries. 1970. Nutrition 13:250–2.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Bingham S, Welch A, et al. (2001). Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet 357:657–63.
   PubMed Web of Science ®Google Scholar
• Kheirolomoom A, Kim CW, Seo JW, et al. (2015). Multifunctional nanoparticles facilitate molecular targeting and miRNA delivery to inhibit atherosclerosis in ApoE(-/-) mice. ACS Nano 9:8885–97.
   PubMed Web of Science ®Google Scholar
• Khemani M, Sharon M, Sharon M. (2012). Encapsulation of berberine in nano-sized PLGA synthesized by emulsification method. ISRN Nanotechnol 2012:1–9.
   Google Scholar
• Kim D, Park S, Jae HL, et al. (2007). Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 129:7661–5.
   PubMed Web of Science ®Google Scholar
• Kim K, Huang S-W, Ashkenazi S, et al. (2007). Photoacoustic imaging of early inflammatory response using gold nanorods. Appl Phys Lett 90:223901.
   Web of Science ®Google Scholar
• Kishimoto Y, Yoshida H, Kondo K. (2016). Potential anti-atherosclerotic properties of astaxanthin. Mar Drugs 14:35.
   PubMed Web of Science ®Google Scholar
• Kong W, Wei J, Abidi P, et al. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344–51.
   PubMed Web of Science ®Google Scholar
• Kooi ME, Cappendijk VC, Cleutjens KBJM, et al. (2003). Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107:2453–8.
   PubMed Web of Science ®Google Scholar
• Korzeniowska K, Cieślewicz A, Pawlaczyk M, et al. (2017). Angioedema after angiotensin-converting enzyme inhibitors. Acta Pol Pharm – Drug Res 74:983–6.
   PubMed Web of Science ®Google Scholar
• Koscielny J. (1999). The antiatherosclerotic effect of Allium sativum. Atherosclerosis 144:237–49.
   PubMed Web of Science ®Google Scholar
• Kostyuk VA, Potapovich AI, Suhan TO, et al. (2011). Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation. Eur J Pharmacol 658:248–56.
   PubMed Web of Science ®Google Scholar
• Kosuge H, Sherlock SP, Kitagawa T, et al. (2012). Near infrared imaging and photothermal ablation of vascular inflammation using single-walled carbon nanotubes. J Am Heart Assoc 1:e002568.
   PubMed Web of Science ®Google Scholar
• Kromhout D, Keys A, Aravanis C, et al. (1989). Food consumption patterns in the 1960s in seven countries. Am J Clin Nutr 49:889–94.
   PubMed Web of Science ®Google Scholar
• Lee DY, Li H, Lim HJ, et al. (2012). Anti-inflammatory activity of sulfur-containing compounds from garlic. J Med Food 15:992–9.
   PubMed Web of Science ®Google Scholar
• Lee S. (2014). Monocytes: a novel drug delivery system targeting atherosclerosis. J Drug Target 22:138–45.
   PubMed Web of Science ®Google Scholar
• Lee T-S, Pan C-C, Peng C-C, et al. (2010). Anti-atherogenic effect of berberine on LXRα-ABCA1-dependent cholesterol efflux in macrophages. J Cell Biochem 111:104–10.
   PubMed Web of Science ®Google Scholar
• Leslie MA, Cohen DJA, Liddle DM, et al. (2015). A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids Health Dis 14:53.
   PubMed Web of Science ®Google Scholar
• Leuschner F, Dutta P, Gorbatov R, et al. (2011). Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 29:1005–10.
   PubMed Web of Science ®Google Scholar
• Levantesi G, Marfisi RM, Mozaffarian D, et al. (2013). Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trial. Int J Cardiol 163:282–7.
   PubMed Web of Science ®Google Scholar
• Li W, Chen X. (2015). Gold nanoparticles for photoacoustic imaging. Nanomedicine 10:299–320.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang L, Jia Z, et al. (2014). A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. PLoS One 9:e98611.
   PubMed Web of Science ®Google Scholar
• Li YH, Yang P, Kong W-J, et al. (2009). Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy. J Med Chem 52:492–501.
   PubMed Web of Science ®Google Scholar
• Libby P. (2002). Inflammation in atherosclerosis. Nature 420:868–74.
   PubMed Web of Science ®Google Scholar
• Liu T, Li J, Liu Y, et al. (2012). Short-Chain fatty acids suppress lipopolysaccharide-Induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB Pathway in RAW264.7 cells. Inflammation 35:1676–84.
   PubMed Web of Science ®Google Scholar
• Lobatto ME, Fayad ZA, Silvera S, et al. (2010). Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. Mol Pharm 7:2020–9.
   PubMed Web of Science ®Google Scholar
• Lobatto ME, Fuster V, Fayad ZA, Mulder WJM. (2011). Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov 10:963.
   PubMed Web of Science ®Google Scholar
• Ma S, Tain XY, Zhang Y, et al. (2016). E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis. Sci Rep 6:22910.
   PubMed Web of Science ®Google Scholar
• Majmudar MD, Yoo J, Keliher EJ, et al. (2013). Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res 112:755–61.
   PubMed Web of Science ®Google Scholar
• Mangas-Cruz MA, Fernández-Moyano A, Albi T, et al. (2001). Effects of minor constituents (non-glyceride compounds) of virgin olive oil on plasma lipid concentrations in male Wistar rats. Clin Nutr 20:211–5.
   PubMed Web of Science ®Google Scholar
• Marrache S, Dhar S. (2013). Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis. Proc Natl Acad Sci USA 110:9445–50.
   PubMed Web of Science ®Google Scholar
• Marzocchella L, Fantini M, Benvenuto M, et al. (2011). Dietary flavonoids: molecular mechanisms of action as anti-inflammatory agents. Recent Pat Inflamm Allergy Drug Discov 5:200–20.
   PubMedGoogle Scholar
• Masoudi Asil S, Ahlawat J, Guillama Barroso G, Narayan M. (2020). Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomater Sci 8:4109–28.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, D’Uscio LV, Eguchi D, et al. (2003). Protective effect of chronic vitamin C treatment on endothelial function of apolipoprotein E-deficient mouse carotid artery. J Pharmacol Exp Ther 306:103–8.
   PubMed Web of Science ®Google Scholar
• Matuszak J, Lutz B, Sekita A, et al. (2018). Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles. Int J Nanomedicine 13:8443–60.
   PubMed Web of Science ®Google Scholar
• Meng N, Gong Y, Zhang J, et al. (2019). A novel curcumin-loaded nanoparticle restricts atherosclerosis development and promotes plaques stability in apolipoprotein E deficient mice. J Biomater Appl 33:946–54.
   PubMed Web of Science ®Google Scholar
• Menzel T, Lührs H, Zirlik S, et al. (2004). Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflamm Bowel Dis 10:122–8.
   PubMed Web of Science ®Google Scholar
• Miles EA, Wallace FA, Calder PC. (2000). Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. Atherosclerosis 152:43–50.
   PubMed Web of Science ®Google Scholar
• Mo H, Fu C, Wu Z, et al. (2020). IL-6-targeted ultrasmall superparamagnetic iron oxide nanoparticles for optimized MRI detection of atherosclerotic vulnerable plaques in rabbits. RSC Adv 10:15346–53.
   PubMed Web of Science ®Google Scholar
• Moreno PR. (2001). Pathophysiology of plaque disruption and thrombosis in acute ischemic syndromes. J Stroke Cerebrovasc Dis 10:2–9.
   PubMedGoogle Scholar
• Morrison M, van der Heijden R, Heeringa P, et al. (2014). Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis 233:149–56.
   PubMed Web of Science ®Google Scholar
• Moss JWE, Ramji DP. (2016). Nutraceutical therapies for atherosclerosis. Nat Rev Cardiol 13:513–32.
   PubMed Web of Science ®Google Scholar
• Musunuru K, Kathiresan S. (2016). Surprises from genetic analyses of lipid risk factors for atherosclerosis. Circ Res 118:579–85.
   PubMed Web of Science ®Google Scholar
• Nair HB, Sung B, Yadav VR, et al. (2010). Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 80:1833–43.
   PubMed Web of Science ®Google Scholar
• Nakano K, Egashira K, Masuda S, et al. (2009). Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology. efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc Interv 2:277–83.
   PubMed Web of Science ®Google Scholar
• Nakashiro S, Matoba T, Umezu R, et al. (2016). Pioglitazone-incorporated nanoparticles prevent plaque destabilization and rupture by regulating monocyte/macrophage differentiation in ApoE -/-Mice. Arterioscler Thromb Vasc Biol 36:491–500.
   PubMed Web of Science ®Google Scholar
• Narain A, Asawa S, Chhabria V, Patil-Sen Y. (2017). Cell membrane coated nanoparticles: next-generation therapeutics. Nanomedicine 12:2677–92.
   PubMed Web of Science ®Google Scholar
• Nashed B, Yeganeh B, HayGlass KT, Moghadasian MH. (2005). Antiatherogenic effects of dietary plant sterols are associated with inhibition of proinflammatory cytokine production in Apo E-KO mice. J Nutr 135:2438–44.
   PubMed Web of Science ®Google Scholar
• Newby AC. (2007). Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med 17:253–8.
   PubMed Web of Science ®Google Scholar
• Niki T, Wakatsuki T, Yamaguchi K, et al. (2016). Effects of the addition of eicosapentaenoic acid to strong statin therapy on inflammatory cytokines and coronary plaque components assessed by integrated backscatter intravascular ultrasound. Circ J 80:450–60.
   PubMed Web of Science ®Google Scholar
• Olszanecki R, Jawien J, Gajda M, et al. (2005). Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol 56:627–35.
   PubMed Web of Science ®Google Scholar
• Osganian SK, Stampfer MJ, Rimm E, et al. (2003). Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol 42:246–52.
   PubMed Web of Science ®Google Scholar
• Pereira MA, O’Reilly E, Augustsson K, et al. (2004). Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164:370–6.
   PubMed Web of Science ®Google Scholar
• Peter L. (1995). Molecular bases of the acute coronary syndromes. Circulation 91:2844–2850.
   PubMed Web of Science ®Google Scholar
• Petersen LK, York AW, Lewis DR, et al. (2014). Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation. Mol Pharm 11:2815–24.
   PubMed Web of Science ®Google Scholar
• Peterson JJ, Dwyer JT, Jacques PF, Mccullough ML. (2012). Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev 70:491–508.
   PubMed Web of Science ®Google Scholar
• Pham LM, Kim E-C, Ou W, et al. (2021). Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis. Biomaterials 269:120677.
   PubMed Web of Science ®Google Scholar
• Pillai SC, Borah A, Jindal A, et al. (2020). BioPerine encapsulated nanoformulation for overcoming drug-resistant breast cancers. Asian J Pharm Sci 15:701–12.
   PubMed Web of Science ®Google Scholar
• Qiu LY, Bae YH. (2006). Polymer architecture and drug delivery. Pharm Res 23:1–30.
   PubMed Web of Science ®Google Scholar
• Ramírez-Tortosa MC, Mesa MD, Aguilera MC, et al. (1999). Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147:371–8.
   PubMed Web of Science ®Google Scholar
• Ramji DP. (2019). Polyunsaturated fatty acids and atherosclerosis: insights from pre-clinical studies. Eur J Lipid Sci Technol 121:1800029.
   Web of Science ®Google Scholar
• Ras RT, Geleijnse JM, Trautwein EA. (2014). LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br J Nutr 112:214–9.
   PubMed Web of Science ®Google Scholar
• Rashid I, van Reyk DM, Davies MJ. (2007). Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. FEBS Lett 581:1067–70.
   PubMed Web of Science ®Google Scholar
• Rodrigueza WV, Phillips MC, Williams KJ. (1998). Structural and metabolic consequences of liposome-lipoprotein interactions. Adv Drug Deliv Rev 32:31–43.
   PubMed Web of Science ®Google Scholar
• Rosenson RS. (2004). Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 173:1–12.
   PubMed Web of Science ®Google Scholar
• Ruehm SG, Corot C, Vogt P, et al. (2001). Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103:415–22.
   PubMed Web of Science ®Google Scholar
• Ruiz-León AM, Lapuente M, Estruch R, Casas R. (2019). Clinical advances in immunonutrition and atherosclerosis: a review. Front Immunol 10:837.
   PubMed Web of Science ®Google Scholar
• Salama L, Pastor ER, Stone T, Mousa SA. (2020). Emerging nanopharmaceuticals and nanonutraceuticals in cancer management. Biomedicines 8:347.
   PubMed Web of Science ®Google Scholar
• Sanchez-Gaytan BL, Fay F, Lobatto ME, et al. (2015). HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages. Bioconjug Chem 26:443–51.
   PubMed Web of Science ®Google Scholar
• Schiener M, Hossann M, Viola JR, et al. (2014). Nanomedicine-based strategies for treatment of atherosclerosis. Trends Mol Med 20:271–281.
   PubMed Web of Science ®Google Scholar
• Schini-Kerth VB, Auger C, Étienne-Selloum N, Chataigneau T. (2010). Polyphenol-induced endothelium-dependent relaxations. 60:133–175.
   Google Scholar
• Scoditti E, Calabriso N, Massaro M, et al. (2012). Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch Biochem Biophys 527:81–89.
   PubMed Web of Science ®Google Scholar
• Shah R, Patel T, Freedman JE. (2018). Circulating extracellular vesicles in human disease. N Engl J Med 379:958–966.
   PubMed Web of Science ®Google Scholar
• Sharis PJ, Cannon CP, Loscalzo J. (1998). The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 129:394.
   PubMed Web of Science ®Google Scholar
• Sinha A, Shaporev A, Nosoudi N, et al. (2014). Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomed Nanotechnol, Biol Med 10:e1003–12.
   PubMed Web of Science ®Google Scholar
• Skålén K, Gustafsson M, Rydberg EK, et al. (2002). Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750–4.
   PubMed Web of Science ®Google Scholar
• Sofi F, Macchi C, Abbate R, et al. (2014). Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr 17:2769–82.
   PubMed Web of Science ®Google Scholar
• Soler-Rivas C, Espiń JC, Wichers HJ. (2000). Oleuropein and related compounds. J Sci Food Agric 80:1013–23.
   Web of Science ®Google Scholar
• Song Y, Zhang L-J, Li H, et al. (2013). Polyunsaturated fatty acid relatively decreases cholesterol content in THP-1 macrophage-derived foam cell: partly correlates with expression profile of CIDE and PAT members. Lipids Health Dis 12:111.
   PubMed Web of Science ®Google Scholar
• Sophie Maiocchi EB, Sydney T, Ana C, et al. (2020).Targeting of atherosclerotic plaque is achieved with polymeric nanoparticles encapsulating Nrf2 activator and LDL-like nanoparticles. bioRxiv
   Google Scholar
• Squillaro T, Cimini A, Peluso G, et al. (2018). Nano-delivery systems for encapsulation of dietary polyphenols: an experimental approach for neurodegenerative diseases and brain tumors. Biochem Pharmacol 154:303–17.
   PubMed Web of Science ®Google Scholar
• Sukhova PLGK, Schönbeck U, Rabkin E. et al. (1999). Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99:2503–9.
   PubMed Web of Science ®Google Scholar
• Sun T, Simmons R, Huo D, et al. (2016). Targeted delivery of anti-miR-712 by VCAM1-binding Au nanospheres for atherosclerosis therapy. ChemNanoMat 2:400–6.
   Web of Science ®Google Scholar
• Takai S, Jin D, Kawashima H, et al. (2009). Anti-atherosclerotic effects of dihomo-γ-linolenic acid in ApoE-deficient mice. J Atheroscler Thromb 16:480–9.
   PubMed Web of Science ®Google Scholar
• Tangney CC, Rasmussen HE. (2013). Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep 15:324.
   PubMed Web of Science ®Google Scholar
• Tarin C, Carrill M, Martin-Ventura JL, et al. (2015). Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI. Sci Rep 5:17135.
   PubMed Web of Science ®Google Scholar
• Taylor M, Moore S, Mourtas S, et al. (2011). Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer’s Aβ peptide. Nanomed Nanotechnol, Biol Med 7:541–50.
   PubMed Web of Science ®Google Scholar
• Tegos TJ, Kalodiki E, Sabetai MM, Nicolaides AN. (2001). The genesis of atherosclerosis and risk factors: a review. Angiology 52:89–98.
   PubMed Web of Science ®Google Scholar
• The Emerging Risk Factors Collaboration. (2009). Lipoprotein (a) concentration and the risk of coronary heart disease, stroke. JAMA 302:412–23.
   PubMed Web of Science ®Google Scholar
• Tinahones FJ, Rubio MA, Garrido-Sánchez L, et al. (2008). Green tea reduces LDL oxidability and improves vascular function. J Am Coll Nutr 27:209–13.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Plastiras A, Siasos G, et al. (2014). Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis 232:10–6.
   PubMed Web of Science ®Google Scholar
• Voloshyna I, Hai O, Littlefield MJ, et al. (2013). Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine. Eur J Pharmacol 698:299–309.
   PubMed Web of Science ®Google Scholar
• Wang B, Yantsen E, Larson T, et al. (2009). Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques. Nano Lett 9:2212–7.
   PubMed Web of Science ®Google Scholar
• Wang D, Yan X, Xia M, et al. (2014). Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1/miR-378/ATP-binding cassette transporter G1-signaling pathway. Arterioscler Thromb Vasc Biol 34:1860–70.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang M, Liang B, et al. (2011). Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. PLoS One 6:e25436.
   PubMed Web of Science ®Google Scholar
• Wang R. (2012). Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92:791–896.
   PubMed Web of Science ®Google Scholar
• Wang Y-XJ. (2011). Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 1:35–40.
   PubMedGoogle Scholar
• Watson RDS, Chin BSP, Lip GYH. (2002). Antithrombotic therapy in acute coronary syndromes. BMJ 325:1348–51.
   PubMed Web of Science ®Google Scholar
• Weissleder R, Elizondo G, Wittenberg J, et al. (1990). Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175:489–93.
   PubMed Web of Science ®Google Scholar
• Weissleder R, Lee AS, Fischman AJ, et al. (1991). Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. Radiology 181:245–9.
   PubMed Web of Science ®Google Scholar
• Widmer RJ, Freund MA, Flammer AJ, et al. (2013). Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur J Nutr 52:1223–31.
   PubMed Web of Science ®Google Scholar
• Woollard KJ, Geissmann F. (2010). Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7:77–86.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2015). Cardiovascular and W. H. O. C. diseases (CVDs). https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1.
   Google Scholar
• Wu YW, Goubran H, Seghatchian J, Burnouf T. (2016). Smart blood cell and microvesicle-based Trojan horse drug delivery: merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine. Transfus Apher Sci 54:309–18.
   PubMed Web of Science ®Google Scholar
• Xue Y, Wu Y, Wang Q, et al. (2019). Cellular vehicles based on neutrophils enable targeting of atherosclerosis. Mol Pharm 16:3109–20.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. (2013). Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des 19:1994–2010.
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Bao C, Ferlito M, Lowenstein CJ. (2008). Epigallocatechin gallate inhibits endothelial exocytosis. Biol Chem 389:935–41.
   PubMed Web of Science ®Google Scholar
• Yang L, Zang G, Li J, et al. (2020). Cell-derived biomimetic nanoparticles as a novel drug delivery system for atherosclerosis: predecessors and perspectives. Regen Biomater 7:349–58.
   PubMed Web of Science ®Google Scholar
• Younes M, Aggett P, Aguilar F, et al. (2018). Scientific opinion on the safety of monacolins in red yeast rice. EFSA J 16:e05368.
   PubMed Web of Science ®Google Scholar
• Zaitsev S, Danielyan K, Murciano J-C, et al. (2006). Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood 108:1895–902.
   PubMed Web of Science ®Google Scholar
• Zanardo RCO, Brancaleone V, Distrutti E, et al. (2006). Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation. FASEB J 20:2118–20.
   PubMed Web of Science ®Google Scholar
• Zhang XQ, Even-Or O, Xu X, et al. (2015). Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis. Adv Healthc Mater 4:228–36.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Koradia A, Kamato D, et al. (2019). Treatment of atherosclerotic plaque: perspectives on theranostics. J Pharm Pharmacol 71:1029–43.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Yang SH, Li MH, et al. (2014). Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. Clin Exp Pharmacol Physiol 41:995–1002.
   PubMed Web of Science ®Google Scholar
• Zhao ZZ, Wang Z, Li G-H, et al. (2011). Hydrogen sulfide inhibits macrophage-derived foam cell formation. Exp Biol Med 236:169–76.
   PubMed Web of Science ®Google Scholar
• Zhu L, Zhang D, Zhu H, et al. (2018). Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe-/- mice. Atherosclerosis 268:117–26.
   PubMed Web of Science ®Google Scholar
• Zimmermann TS, Lee ACH, Akinc A, et al. (2006). RNAi-mediated gene silencing in non-human primates. Nature 441:111–4.
   PubMed Web of Science ®Google Scholar